Pethidine (Meperidine) Uses Dosages Warnings and Side Effects

Meperidine (Pethidine) is an opioid analgesic that has been used medically to relieve moderate to severe pain in certain situations. It is characterized by a relatively rapid onset of analgesic action when administered by injection. Despite its effectiveness in pain relief, its use requires careful medical supervision and monitoring due to the possibility of side effects and complications, particularly when used at inappropriate doses or for prolonged periods.In we will discuss Meperidine (Pethidine), including its main uses, methods of administration and dosing, side effects, and the important precautions and warnings that should be considered to ensure its safe use under medical supervision.

What is Pethidine (Meperidine)?

Pethidine (Meperidine), also known as Demerol, is a strong synthetic opioid analgesic used to relieve moderate to severe pain, including postoperative pain and pain during labor.

How long does Pethidine last?

Its analgesic effect usually lasts for approximately 2–4 hours after injection. The duration may vary depending on the dose, route of administration, and the person’s health condition.

Pethidine usually begins to take effect within 5–10 minutes when administered intravenously (IV) and approximately 10–15 minutes when administered intramuscularly (IM).

Although the pain-relieving effect wears off within several hours, the drug and its metabolites may remain in the body for a longer period.

Side Effects and Warnings

Pethidine may cause drowsiness, dizziness, and respiratory depression. The risk of these effects may increase when it is used together with alcohol, sedatives, or other opioid medications.

Therefore, Pethidine should be used under medical supervision and according to the dose prescribed by a doctor.

Can Pethidine Injection Cause Addiction?

Yes. Pethidine belongs to the opioid class of medications, which can cause physical or psychological dependence and addiction, particularly when used for long periods or at doses higher than medically recommended.

For this reason, it is generally used for short periods and under medical supervision, according to the patient’s needs and health condition.

Does Pethidine Affect the Baby During Labor?

Yes. Pethidine can cross the placenta and may therefore affect the newborn, particularly when administered to the mother close to the time of delivery.

This may appear as drowsiness or temporary breathing difficulties after birth. Therefore, the medical team monitors both the mother and the baby and manages any effects that may occur according to standard medical procedures.

Can I Drive After Receiving a Pethidine Injection?

Driving is not recommended after receiving Pethidine. The medication may cause drowsiness, dizziness, impaired concentration, confusion, or blurred vision, which can affect the ability to drive safely and may put the person and others at risk.

You should also avoid operating machinery or performing activities that require alertness and concentration until the effects of the medication have worn off, according to your doctor’s instructions.

Can People with Diabetes Use Pethidine?

A person with diabetes may be able to use Pethidine when medically necessary. However, you should inform your doctor that you have diabetes and provide a complete list of all medications you are taking before receiving the drug.

The doctor will determine whether Pethidine is appropriate based on your overall health, liver and kidney function, and other medications you are taking.

Can Pethidine Be Taken with Alcohol?

No. Alcohol should be avoided while using Pethidine. Combining the two can increase central nervous system depression, potentially causing severe drowsiness, decreased consciousness, slow or difficult breathing, and other potentially serious effects.

Can Pethidine Be Used with Sedatives?

Pethidine should generally not be combined with sedatives or sleeping medications, particularly benzodiazepines, unless under direct medical supervision.

Combining these medications can increase sedation and central nervous system depression and may lead to dangerous respiratory depression.

Does Pethidine Cause Addiction?

Yes. Pethidine is an opioid medication that can cause physical and psychological dependence and addiction, particularly when used repeatedly, for prolonged periods, or at doses that have not been medically prescribed.

Can Pethidine Be Given to Children or Older Adults?

The use of pethidine in children and older adults requires careful medical evaluation. Some of these groups may be more susceptible to side effects, including severe drowsiness and respiratory depression. Therefore, the doctor determines whether the medication is appropriate and selects the suitable dose according to the patient’s medical condition.

What Should I Do If I Miss a Dose?

Do not take an extra or double dose to make up for a missed dose. The appropriate action depends on the formulation, route of administration, and the doctor’s instructions. Therefore, it is preferable to consult a doctor or pharmacist for appropriate guidance.

Can Pethidine Be Stopped Suddenly?

If pethidine has been used repeatedly or for a prolonged period, suddenly stopping it may cause withdrawal symptoms. Therefore, it should not be discontinued without consulting a doctor. The doctor may recommend gradually reducing the dose depending on the patient’s condition and duration of use.

Is Meperidine Suitable for All Types of Pain?

No. The choice of an appropriate painkiller depends on the type and severity of the pain, the patient’s medical condition, liver and kidney function, and other medications being taken. Therefore, meperidine is not appropriate for all types of pain, and its suitability should be determined by a doctor for eachethidine, is a potent opioid analgesic that is subject to medical control. Therefore, the doctor should determine the appropriate dose, route of administration, and duration of treatment because of the risk of respiratory depression, individual case.

Benefits and Uses of Pethidine

Pethidine, also known as meperidine, is an opioid analgesic used in certain medical situations to relieve pain. Its main uses include:

Relief of moderate to severe acute pain: Pethidine primarily acts on opioid receptors, particularly mu-opioid receptors, reducing the transmission of nerve signals associated with pain perception.
Relief of postoperative pain: It may be used for a short period to relieve acute pain following certain surgical procedures, according to the doctor’s assessment.
Relief of labor pain: In some cases, pethidine may be used to relieve pain during labor. The decision depends on the mother’s condition, the stage of labor, and the assessment of the medical team.
Reduction of shivering and chills after anesthesia: One of the distinctive uses of pethidine is its ability to help reduce shivering that may occur after anesthesia or certain surgical procedures. It may therefore be used for this purpose in specific medical settings.
As an adjunct to anesthesia: It may be used before or during certain surgical procedures as part of an anesthesia and pain-management plan, according to the anesthesiologist’s judgment.
Relatively rapid onset and short duration of action: Pethidine has a relatively rapid onset of action and a relatively short duration of effect, which may make it suitable in some situations requiring short-term pain relief under medical supervision.

Important note: Pethidine is not appropriate for all types of pain. Its use depends on the patient’s condition, the severity of the pain, other medications being used, and potential risks.

What Are the Doses of Meperidine (Pethidine) and How Is It Administered?

Meperidine, also known as pethidine, is a potent opioid analgesic that is subject to medical control. Therefore, the doctor should determine the appropriate dose, route of administration, and duration of treatment because of the risk of respiratory depression, drug dependence, and overdose.

Official prescribing information recommends using the lowest effective dose for the shortest possible duration, while taking the patient’s condition and other medications into consideration.

Usual Adult Doses

For acute pain relief: The usual initial dose may range from 50 to 150 mg, administered by intramuscular (IM) or subcutaneous (SC) injection. It may be repeated every 3–4 hours as needed, with dose adjustments based on the patient’s response and the doctor’s assessment.
Before anesthesia or surgery: A dose of approximately 50–100 mg may be administered by intramuscular or subcutaneous injection about 30–90 minutes before anesthesia.
During anesthesia: Meperidine may be administered intravenously (IV) in divided doses and very slowly, or by intravenous infusion. This should be done in a properly equipped medical setting with continuous monitoring. The dose is determined according to the type of anesthesia, the patient’s condition, and the response to treatment.
During labor and delivery: A dose of approximately 50–100 mg may be administered by intramuscular or subcutaneous injection when needed. It may be repeated according to medical assessment, the mother’s condition, and the stage of labor.

Routes of Administration of Meperidine

Injectable meperidine may be administered by several routes, including:

Intramuscular (IM) injection: Used in some cases when repeated doses are required.
Subcutaneous (SC) injection: May be used in certain cases for pain relief.
Intravenous (IV) injection: Used when medically indicated and must be administered very slowly under appropriate medical supervision and monitoring. It is not intended for unsupervised home use.

Use in Children and Older Adults

Doses for children are determined according to weight, age, and medical condition. There is no single dose that is appropriate for all children; therefore, the dose must be determined by a doctor.

Older adults may require lower initial doses and closer monitoring because reduced kidney or liver function may increase the risk of drug or metabolite accumulation and adverseethidine should not be used, or its dose changed or injections repeated, without a prescription and medical supervision because of the risk of severe effects.

Important warning: The doses mentioned above are general drug-information examples and are not a prescription or individualized treatment plan. Meperidine/pethidine should not be used, or its dose changed or injections repeated, without a prescription and medical supervision because of the risk of severe drowsiness, respiratory depression, dependence, and overdose.

What Are the Dosage Forms of Meperidine (Pethidine)?

Meperidine (Meperidine / Pethidine), commonly known as pethidine, is available in several dosage forms. However, the availability and strengths of these formulations may vary depending on the country and manufacturer.

The most common dosage forms include:

Injectable solution: This is one of the most commonly used formulations. Depending on the product and medical indication, it may be administered by intramuscular, subcutaneous, or intravenous injection. Some products may be available in different strengths, such as 25, 50, 75, and 100 mg/mL.
Oral tablets: These were available in some markets in strengths such as 50 and 100 mg, but their use and availability have become limited in many countries because of safety concerns, particularly with repeated or prolonged use.
Oral solution or syrup: Available in some markets, but less commonly used than injectable formulations.

What Are the Drug Interactions of Meperidine (Pethidine)?

Meperidine has several important drug interactions, some of which can be serious. Therefore, the doctor or pharmacist should be informed about all medications and supplements the patient is taking before meperidine is administered.

Potentially Serious Interactions

Monoamine oxidase inhibitors (MAOIs): Such as phenelzine and tranylcypromine, as well as linezolid and certain situations involving intravenous methylene blue. Combining meperidine with these medications is contraindicated in certain circumstances, and an appropriate interval after discontinuing MAOIs should be observed according to medical guidance. The combination may cause serious effects, including respiratory depression, blood-pressure disturbances, hyperthermia, seizures, or serotonin syndrome.
Benzodiazepines, sedatives, and hypnotics: Such as diazepam, alprazolam, and clonazepam, as well as certain antipsychotics and muscle relaxants. Combining these medications with meperidine may cause profound sedation and respiratory depression, which in severe cases can lead to loss of consciousness or death.
Alcohol: Alcohol can increase the sedative and respiratory-depressant effects of meperidine. Therefore, combining alcohol with meperidine can be dangerous and should be avoided.
Other opioids: Such as morphine, fentanyl, oxycodone, and hydrocodone. Combining opioids may increase central nervous system and respiratory depression. They should therefore only be used together under careful medical supervision.

Medications That May Increase the Risk of Serotonin Syndrome

Meperidine may increase the risk of serotonin syndrome when used with certain medications that affect serotonin levels in the body, including:

Selective serotonin reuptake inhibitors (SSRIs): Such as sertraline, fluoxetine, and escitalopram.
Serotonin-norepinephrine reuptake inhibitors (SNRIs): Such as venlafaxine and duloxetine.
Some tricyclic antidepressants.
Tramadol.
Trazodone and mirtazapine.
Some migraine medications in the triptan class.
Certain antiemetic medications.
Some muscle relaxants, such as cyclobenzaprine.

What Are the Symptoms of Serotonin Syndrome?

Serotonin syndrome may present with:

Agitation or confusion
Severe sweating
Increased body temperature
Tremor
Diarrhea
Rapid heartbeat
Altered level of consciousness
Seizures

If severe or worsening symptoms occur after combining meperidine with a medication that affects serotonin, urgent medical attention should be sought.

Medications That Affect Meperidine (Pethidine) Concentrations

Some medications may affect the metabolism of meperidine, potentially increasing its blood concentration and the risk of adverse effects, or decreasing its concentration and reducing its effectiveness. Therefore, the doctor should be informed about all medications the patient is taking before meperidine is administered.

Liver Enzyme Inhibitors

Some medications that inhibit enzymes such as CYP3A4 and CYP2B6 may increase meperidine concentrations or alter its metabolism, potentially increasing the risk of toxicity and respiratory depression. Examples include some macrolide antibiotics, certain azole antifungals, and ritonavir.

Liver Enzyme Inducers

Medications such as rifampin, carbamazepine, and phenytoin may increase the metabolism of meperidine and reduce its concentration or effect.

Stopping one of these enzyme-inducing medications may subsequently result in an increase in meperidine concentrations. Therefore, the dose may need to be reassessed and the patient monitored appropriately.

Other Important Drug Interactions

Buprenorphine, nalbuphine, pentazocine, and butorphanol: These medications may reduce the analgesic effect of meperidine and may precipitate withdrawal symptoms in people who are physically dependent on opioids. They should therefore not be combined except following medical evaluation and supervision.
Gabapentin and pregabalin: Using these medications with meperidine may increase central nervous system depression, including increased drowsiness and the risk of respiratory depression, particularly in people who are more susceptible to these complications.
Anticholinergic medications: Combining them with meperidine may increase certain adverse effects, such as constipation and urinary retention. In severe cases, the risk of reduced or paralyzed intestinal motility may increase.
Acyclovir: Acyclovir may affect the levels of meperidine and its metabolite, normeperidine. Therefore, the combination may require careful medical monitoring, particularly in patients with impaired kidney function.

Contraindications of Meperidine (Pethidine)

According to official prescribing information, there are circumstances in which meperidine is absolutely contraindicated, while other conditions require extreme caution and careful medical assessment before use.

1. Absolute Contraindications

Severe respiratory depression: Meperidine is contraindicated in patients with significant respiratory depression because it may worsen hypoventilation and slow breathing, potentially resulting in respiratory failure or death.
Acute or severe bronchial asthma: It is contraindicated in acute or severe asthma, particularly when the patient is not being adequately monitored or when appropriate resuscitation equipment is not available.
Use of monoamine oxidase inhibitors (MAOIs): Meperidine is contraindicated in patients taking MAO inhibitors, such as phenelzine or tranylcypromine, or in patients who have discontinued these medications within the previous 14 days. Combining them may cause serious reactions, including severe respiratory depression, blood-pressure disturbances, hyperthermia, coma, and seizures, and these complications may be life-threatening.
Known or suspected intestinal obstruction: This includes paralytic ileus, because opioids can slow intestinal motility and potentially worsen the obstruction.
Hypersensitivity to meperidine: Meperidine should not be used in patients with a known allergy to meperidine or any component of the formulation, particularly if they have previously experienced a severe allergic reaction.

2. Conditions Requiring Extreme Caution

These conditions are not necessarily absolute contraindications but require careful medical assessment and appropriate monitoring:

Epilepsy or a history of seizures: Meperidine may increase the risk of seizures, particularly with repeated administration. This is associated with accumulation of its active metabolite, normeperidine.
Impaired kidney function: Meperidine should be used with extreme caution because normeperidine is primarily eliminated through the kidneys. Kidney impairment may lead to its accumulation and increase the risk of neurotoxicity and seizures.
Impaired liver function: Meperidine metabolism may be affected in patients with liver impairment. Treatment may therefore need to be adjusted, with appropriate clinical monitoring.
Head injuries, increased intracranial pressure, brain tumors, and altered consciousness: Respiratory depression caused by meperidine may increase carbon dioxide levels, which can raise intracranial pressure. The drug may also mask some signs of neurological deterioration. Therefore, extreme caution is required, and its use should generally be avoided in coma or significantly reduced consciousness unless carefully evaluated by a medical professional.
Circulatory shock: Avoiding meperidine is recommended in cases of circulatory shock because it may potentially worsen cardiovascular and respiratory instability.
Biliary tract disease and pancreatitis: Meperidine may cause spasm of the sphincter of Oddi. Therefore, patients with biliary tract disease or pancreatitis should be carefully assessed and monitored.
Long-term use for pain management: Chronic use of meperidine for pain is generally not recommended because repeated or prolonged administration may lead to accumulation of normeperidine and increase the risk of neurotoxicity, including seizures.

3. Drug Interactions and Sedatives Requiring Special Attention

Even when no absolute contraindication is present, extreme caution is required when meperidine is combined with alcohol, benzodiazepines, other opioids, or sedative medications. Such combinations may cause severe central nervous system and respiratory depression, potentially leading to coma or death.

Caution is also required when meperidine is used together with medications that affect the serotonergic system, as this may increase the risk of serotonin syndrome, a potentially serious condition requiring urgent medical attention.

Long-Term Effects of Pethidine

The long-term effects of pethidine (meperidine) are particularly important when it is used repeatedly or for prolonged periods. Pethidine is an opioid analgesic that is generally not recommended for chronic pain treatment because the risk of toxicity increases with continued use, particularly because of the accumulation of its metabolite normeperidine.

1. Dependence and Addiction

Because pethidine is an opioid, repeated use may lead to:

Tolerance: The need for higher doses to achieve the same effect.
Physical dependence: The body adapts to the presence of the drug, and withdrawal symptoms may occur if it is stopped abruptly.
Opioid use disorder or addiction: This can occur with misuse and may also occur in some individuals even when the medication is used therapeutically under medical supervision.

Withdrawal symptoms may include anxiety, sweating, chills, muscle aches, runny nose, insomnia, nausea, vomiting, and diarrhea.

Therefore, if pethidine has been used continuously and physical dependence has developed, it should not be stopped abruptly without medical advice. The dose may need to be reduced gradually under medical supervision.

2. Normeperidine: A Major Risk of Prolonged Use

One of the most important features distinguishing pethidine from many other opioid analgesics is its metabolite normeperidine.

Pethidine is metabolized in the liver to normeperidine, a metabolite with neurotoxic effects that can accumulate in the body when doses are repeated. Normeperidine is primarily eliminated through the kidneys, so the risk of accumulation is higher in people with impaired kidney function.

Accumulation of normeperidine may increase neuronal excitability and cause symptoms such as:

Tremor or shaking
Muscle twitching
Increased reflexes
Hallucinations
Confusion or delirium
Seizures in cases of severe toxicity

Therefore, the risk of normeperidine accumulation is one of the main reasons prolonged use of pethidine is discouraged.

3. Effects on the Nervous System

Continuous use or high doses of pethidine may cause neurological effects, including:

Drowsiness and lethargy
Dizziness and impaired concentration
Confusion
Mood changes
Hallucinations
Tremor
Involuntary muscle movements
Seizures in cases of toxicity

These risks are particularly important in older adults and in people with impaired kidney or liver function.

4. Respiratory Depression

Like other opioid analgesics, pethidine can suppress the respiratory center in the brain. The risk of respiratory depression increases with high doses, dose escalation, or concomitant use of alcohol or sedative medications such as benzodiazepines.

In cases of overdose, severe respiratory depression may lead to loss of consciousness and coma and can be life-threatening.

5. Constipation and Gastrointestinal Disturbances

Repeated use of opioids may cause gastrointestinal problems, including:

Persistent constipation
Nausea and vomiting
Slowed intestinal motility
Abdominal pain or discomfort

These effects are well-known adverse effects associated with opioids, including pethidine.

6. Increased Sensitivity to Pain

Long-term opioid use may, in some patients, lead to a condition known as opioid-induced hyperalgesia, in which the person becomes more sensitive to pain rather than experiencing improved pain control with increasing opioid use.

This may result in a cycle of:

Increased pain → increased opioid use → increased sensitivity to pain.

This phenomenon should be considered when opioids are used for long-term pain management.

7. Hormonal Effects

Chronic opioid use may affect the function of the hypothalamic-pituitary-adrenal axis and may cause hormonal disturbances in some patients, including adrenal insufficiency.

Adrenal insufficiency is an important complication to consider during long-term opioid therapy.

8. Kidney and Liver Function

The kidneys play an important role in eliminating pethidine and its metabolites. Therefore, impaired kidney function may lead to accumulation of normeperidine and increase the risk of neurotoxicity.

Impaired liver function may also affect the metabolism of pethidine and its metabolites, potentially increasing their levels in the body and the likelihood of adverse effects.

It is important to clarify that pethidine is not generally known to directly damage the kidneys simply because it is used. However, pre-existing kidney impairment makes its use more hazardous because of the potential accumulation of the drug and normeperidine.

Treatment of Pethidine Use Disorder

Pethidine (meperidine) use disorder can be treated, preferably under medical supervision, particularly when the medication has been used regularly or in high doses. Abrupt discontinuation after repeated use may cause withdrawal symptoms. In addition, pethidine produces a metabolite known as normeperidine, which can accumulate and cause neurotoxicity with repeated use.

1. Initial Medical Assessment

Treatment generally begins with a comprehensive assessment to determine the degree of dependence and the health risks associated with pethidine use. This may include:

Determining the amount of pethidine being used, the route of administration, and the duration of use.
Assessing kidney and liver function.
Evaluating the patient’s mental health and factors that may contribute to continued use.
Determining whether the person is using other medications or substances at the same time, particularly alcohol, sedatives, and other opioids.

2. Management of Withdrawal Symptoms

Abruptly stopping pethidine is generally not recommended in people who use it daily or at high doses because this may cause significant withdrawal symptoms.

The doctor determines the most appropriate discontinuation strategy according to the patient’s condition. This may involve gradually reducing the dose or transitioning to appropriate medication treatment for opioid use disorder.

3. Long-Term Medication Treatment

There are effective, evidence-based medications for the treatment of opioid use disorder, including:

Buprenorphine: It may be used alone or in combination with naloxone.
Methadone: Usually provided through specialized treatment programs under medical supervision.
Naltrexone: May be appropriate for some patients, but the body must be free of opioids for an appropriate period before starting treatment to avoid precipitating severe withdrawal symptoms.

The doctor selects the most appropriate medication based on the pattern of pethidine use, the patient’s physical and mental health, other medications or substances being used, and other individual factors.

4. Psychological and Behavioral Treatment

Treatment of pethidine use disorder does not rely on medication alone. Psychological and behavioral support is also an important part of treatment.

Psychotherapy may help with:

Identifying triggers that lead to pethidine use.
Managing cravings.
Addressing psychological or social problems associated with drug use.
Developing healthy ways to cope with stress and pressure.
Reducing the risk of relapse.

Combining medication treatment with psychological and behavioral support is generally more effective than relying on detoxification alone.

5. Follow-Up and Overdose Prevention

Ongoing medical follow-up is an important part of treatment, particularly during the early stages of recovery.

After a period of stopping opioid use, the body’s opioid tolerance decreases. Therefore, returning to the dose previously used may cause a dangerous overdose, even if the person had previously tolerated that dose.

For this reason, providing naloxone and training the patient or family members on how to use it in the event of an overdose may be an important part of a safety plan.

Important Tips When Using Pethidine (Meperidine)

Pethidine (meperidine) is a strong opioid analgesic. It requires particular caution because it can cause drowsiness, dizziness, low blood pressure, and respiratory depression. Repeated or inappropriate use may also result in physical dependence and toxicity.

Key Safety Tips

Use pethidine only at the dose and by the route prescribed by your doctor. Do not increase or repeat the dose on your own, even if the pain returns, because an overdose may cause respiratory depression and can be life-threatening.
Avoid alcohol while using pethidine. Combining the two may cause severe drowsiness and respiratory depression and may lead to coma or death.
Do not use pethidine together with sedatives, sleeping medications, or benzodiazepines without medical supervision, including diazepam, alprazolam, and clonazepam. Avoid combining it indiscriminately with other opioids because these combinations may increase the risk of respiratory depression.
Tell your doctor or pharmacist about all medications and supplements you are taking, because some medications may affect pethidine levels in the body or increase its adverse effects.
Be aware of serious interactions with monoamine oxidase inhibitors (MAOIs). Pethidine should not be used concurrently with these medications, and the appropriate interval after discontinuation should be observed according to medical advice.
Pethidine may interact with medications that affect serotonin, increasing the risk of serotonin syndrome. Symptoms may include agitation, severe sweating, increased body temperature, rapid heartbeat, tremor, or muscle rigidity. Seek urgent medical attention if severe or worsening symptoms occur.
Avoid driving or operating machinery if you experience drowsiness, dizziness, or impaired concentration, because pethidine may affect alertness and reaction time.
Stand up slowly from a bed or chair, particularly after receiving pethidine by injection, because the medication may cause low blood pressure and dizziness, increasing the risk of falls.
Tell your doctor before using pethidine if you have kidney or liver disease, respiratory disease, severe asthma, a head injury, altered consciousness, or a history of seizures. Certain risks associated with the medication may be increased in these conditions.
Avoid repeated or prolonged use of pethidine whenever possible. Its metabolite, normeperidine, may accumulate, particularly in people with impaired kidney function, increasing the risk of neurotoxicity and seizures.
Store the medication in a secure place away from children and other people, because accidental ingestion may cause serious or fatal poisoning.